CJC-1295 With DAC
CJC-1295 With DAC
  • SKU: CJC-1295-WITH-DAC-5-MG

CJC-1295 With DAC

23% off
$110.00
$85.00
Third-Party Testing Verifications
ISO Certified Manufacturing
Satisfaction Guaranteed
Dosage: 5 mg
Select The Options Above

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) designed for extended stability in biological systems. The compound is commonly studied in laboratory research for its interaction with growth hormone regulatory pathways, pituitary receptor signaling, and endocrine communication mechanisms.

In laboratory research environments, CJC-1295 with DAC is commonly investigated in studies involving:

• Growth hormone axis signaling pathway research• Pituitary receptor pharmacology• Endocrine regulatory mechanism modeling• Long-acting peptide signaling investigation• Peptide-mediated hormonal communication research

These research areas make CJC-1295 with DAC a valuable compound for laboratories studying growth hormone regulatory pathways and endocrine peptide signaling systems.

CJC-1295 with DAC is a synthetic peptide derived from growth hormone–releasing hormone (GHRH), a naturally occurring hormone responsible for stimulating growth hormone signaling within the hypothalamic–pituitary axis. The peptide belongs to a class of compounds studied for their influence on pituitary receptor activity and endocrine regulatory pathways.

The addition of a Drug Affinity Complex (DAC) allows the peptide to bind to circulating albumin, which can extend the stability and persistence of the compound in biological systems during laboratory investigation. This modification has made CJC-1295 with DAC a compound of interest in research examining longer-acting peptide signaling mechanisms within endocrine pathways.

Because of these structural and functional characteristics, CJC-1295 with DAC has been widely studied in scientific literature exploring growth hormone axis signaling, pituitary receptor activation, and peptide-mediated endocrine communication systems.

Compound Name: CJC-1295 with DAC
Format: Lyophilized peptide powder
Purity: ≥99% (HPLC verified)
Verification: Mass spectrometry confirmed
Storage: Store in a cool, dry environment. Refrigeration recommended for long-term stability.

CJC-1295 with DAC is studied for its interaction with growth hormone–releasing hormone receptors (GHRH receptors) located within the anterior pituitary gland.

Scientific literature frequently examines this peptide in relation to:

• Growth hormone–releasing hormone receptor signaling• Hypothalamic–pituitary endocrine communication pathways• Peptide-mediated hormonal regulatory mechanisms• Albumin-binding peptide stability and extended signaling activity• Growth hormone axis pathway research

These signaling pathways are important areas of investigation in studies exploring endocrine regulatory systems and peptide-driven hormonal communication networks.

  • Free shipping on orders over $50
  • Standard delivery within 2–5 business days
  • Easy 30-day returns
  • Return items in original condition for a full refund
Quality Commitment

All compounds are manufactured using strict analytical and quality control procedures designed to support research reproducibility and compound integrity.

Each production batch undergoes analytical verification testing to confirm purity, molecular identity, and structural stability prior to release.

IMPORTANT NOTICE

This product is supplied strictly for laboratory research use only.

This compound is not intended for human consumption, medical use, veterinary use, or clinical application. Products are sold exclusively for scientific research and laboratory investigation.